Polyneuropathies Clinical Trial
Official title:
Developing and Testing Instrument to Measure Physical Activity in Charcot-Marie-Tooth: a Pilot Project
The project will develop knowledge about physical activity in persons with Charcot-Marie-Tooth (CMT) in Norway. We plan to explore instruments to measure physical activity level for the target-group at the community level. We want to understand which type of activities, activity intensities and how persons with CMT perform habitual physical activity. Subsequently, a physical activity measurement instrument adapted to persons with CMT will be developed. This instrument can be used in a future intervention project to promote physical activity in this group.
Charcot-Marie-Tooth (CMT) is a condition that potentially affects daily life function including physical activity. Currently, there is no specific treatment. To prevent physical deconditioning, physical activity recommended. Furthermore, other studies have found the benefit of being physically active, including people with neuromuscular disorders (NMD). . Apart from the physical activity in a rehabilitation center, physical activity also needs to be maintained at the community level in people's everyday life. To measure physical activity level in the community, we need an instrument that is designed for doing so. A questionnaire can be used to collect information about type of activity, activity duration and intensity. The instruments available so far to measure physical activity at the community level are not specifically adapted to persons with CMT. Therefore, this study will focus on revising the questionnaire based on the inputs from persons with CMT themselves. Furthermore, the revised questionnaire will be compared with the original one in addition to yet another instrument. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06040567 -
Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study
|
||
| Enrolling by invitation |
NCT06359561 -
Assessment of Effectiveness and Stimulation Coverage of Closed-loop Spinal Cord Stimulation (CL-SCS) Therapy in Patients With Cervical Lead Placement
|
||
| Recruiting |
NCT06044662 -
Prognostic Value of Biomarkers in Polyneuropathy.
|
||
| Completed |
NCT00050245 -
Rituximab to Treat Neuropathy With Anti-MAG Antibodies
|
Phase 2 | |
| Not yet recruiting |
NCT01718015 -
Neurotrophic Factors in Cerebrospinal Fluid in Diabetic Patients With Polyneuropathy
|
N/A | |
| Completed |
NCT03765489 -
Electrical Muscle Stimulation in the Development of Acquired Weakness in Patients With Severe Sepsis and Septic Shock
|
N/A | |
| Completed |
NCT01370837 -
Neurogenic Inflammation in Diabetes
|
N/A | |
| Not yet recruiting |
NCT06377033 -
Using the EHR to Advance Genomic Medicine Across a Diverse Health System
|
N/A | |
| Not yet recruiting |
NCT02061059 -
Cost-effectiveness of In-shoe Pressure Measurement for Therapeutic Shoes
|
N/A | |
| Not yet recruiting |
NCT06390527 -
Ultrasonography in Diagnosis of Polyneuropathy
|
||
| Recruiting |
NCT05188690 -
Polyneuropathy and COVID-19
|
||
| Completed |
NCT00231673 -
A Study To Evaluate The Effect Of Topiramate On Clinical And Electrophysiological Parameters In Subjects With Diabetic Peripheral Polyneuropathy
|
Phase 2 | |
| Recruiting |
NCT03237494 -
TRAMmoniTTR Study Genetic Screening of an At-risk Population for hATTR and Monitoring of TTR Positive Subjects
|
||
| Active, not recruiting |
NCT03617185 -
Effect of Exercise and Surgical Weight Loss on Polyneuropathy
|
N/A | |
| Active, not recruiting |
NCT02753036 -
Chemotherapy-induced Cognitive Alterations in Recruits With Ovarian and Breast Cancer
|
||
| Completed |
NCT01263132 -
Neuropathic Pain Management
|
Phase 3 | |
| Terminated |
NCT01867645 -
The Impact of IVIG Treatment on Critical Illness Polyneuropathy and/or Myopathy in Patients With MOF and SIRS/Sepsis
|
Phase 1 | |
| Completed |
NCT00162968 -
Escitalopram as a Treatment for Pain in Polyneuropathy
|
Phase 4 | |
| Completed |
NCT04664426 -
Sensory Neuropathy Scores Validated by Quantitative Sensory Testing and Nerve Conduction Studies for Kidney Transplant Recipients
|
||
| Recruiting |
NCT05023889 -
Spectrum of Peripheral and Autonomic Neuropathies in Patients With aTTRwt Amyloidosis and Response to Patisiran Therapy
|
Early Phase 1 |